Market access

The role of the Market Access as a vehicle for economic growth is becoming increasingly important in time when pharma market undergoes drastic changes in regulation and funding.

Aston Group's expertise and research capabilities make possible delivering solutions with respect to pricing strategies and Market Access at both federal and regional level.

• HTA analysis in collaboration with the leading research environments for Health Economics 
• Pharmacoeconomic evaluation based on the data from more than twenty own Clinical Patient Registries 
• Assessment of the regional potential using the cross-analysis of sales in the reimbursement segment (information from public procurement tenders) and benchmarking with prescription data derived from Clinical Patient Registries - Aston 360 
• Pricing studies 
• Development of Market Access strategies at the federal and regional level 
• Monitoring of regulatory and other changes in health care: PharmCompass Russia and PharmCompass Regions